Randomized, Double-blind, Placebo-controlled, Comparative Study of Human Anti-TNF Antibody Adalimumab in Combination with Methotrexate and Methotrexate Alone in Taiwanese Patients with Active Rheumatoid Arthritis
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference36 articles.
1. Joint inflammation and cytokine inhibition in rheumatoid arthritis;Christodoulou;Clin Exp Med,2006
2. Differential therapy in early and late stages of rheumatoid arthritis;Breedveld;Curr Opin Rheumatol,1996
3. Modeling therapeutic strategies in rheumatoid arthritis: use of decision analysis and Markov models;Albert;J Rheumatol,2000
4. A 36 month comparative trial of methotrexate and gold sodium thioma-late in the treatment of early active and erosive rheumatoid arthritis;Menninger;Br J Rheumatol,1998
5. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO 5. study, a double-blind, randomized trial;van der Heijde;Arthritis Rheum,2006
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative Efficacy of bDMARDs and tsDMARDs for the Treatment of Rheumatoid arthritis: A Systematic Review and Network Meta-Analysis;International Journal of Biology and Life Sciences;2023-06-01
2. Meta‐Analyses on the Effects of Disease‐Modifying Antirheumatic Drugs on the Most Relevant Patient‐Reported Outcome Domains in Rheumatoid Arthritis;Arthritis Care & Research;2023-02-22
3. Bayesian network meta-analysis methods for combining individual participant data and aggregate data from single arm trials and randomised controlled trials;BMC Medical Research Methodology;2022-07-11
4. The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis;Frontiers in Immunology;2022-02-16
5. Risk of Adverse Events After Anti-TNF Treatment for Inflammatory Rheumatological Disease. A Meta-Analysis;Frontiers in Pharmacology;2021-11-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3